Lipid Nanoparticle (LNP) Production Equipment Industry Analysis：the global market size is projected to reach USD 0.3 billion by 2030

Lipid nanoparticles (LNPs) are the most advanced non-viral gene delivery systems in clinical practice. Lipid nanoparticles can overcome a major obstacle in the development and application of genetic drugs, and safely and effectively transport nucleic acids. Gene drugs have many different application fields, such as gene editing, rapid vaccine development, tumor immunotherapy for rare genetic diseases and non-drug-resistant diseases, and so on; All of these application areas are often hindered by low efficiency in nucleic acid delivery. LNP consists of four components: ionized lipid phospholipids, PEG lipids, cholesterol like structures, and lipids. These four components form a sphere with a diameter of about 100 nm, which can encapsulate mRNARNA i gene editing scissors and deliver them into the LNP sphere. The most critical component of LNP is ionized lipids, which are the key components for LNP to escape from its inner body. The new development of medicine has made drugs and their active ingredients increasingly complex and brought new challenges. For example, oligonucleotides are easily degraded in the human body. The latest research suggests that LNPs can form a stable environment for protecting active ingredients such as RNA, mRNA, siRNA, or DNA based APIs. The optimization of nucleic acid drugs and targeted cell delivery pathways is currently a very popular research field. Lipid nanoparticles (LNPs) are commonly used to encapsulate and deliver drugs such as mRNA. The LNP production equipment is used for the preparation and production of these lipid nanoparticles.

Explosive demand for mRNA vaccines: Since the COVID-19 outbreak in 2020, mRNA vaccine technology has gained widespread attention. The production of major vaccines such as Pfizer-BioNTech and Moderna cannot be separated from LNP as a carrier. Therefore, the expansion of the mRNA vaccine market provides huge opportunities for the LNP production equipment market.

Growth of gene therapy: LNP is not only used in vaccines, but also plays a key role in gene therapy. With the maturity of gene therapy technology, especially the development of CRISPR technology, LNP will be more widely used in gene editing, cancer immunotherapy, etc., which provides more market opportunities for new equipment manufacturers.

According to the new market research report “Global Lipid Nanoparticle (LNP) Production Equipment Market Insights, Forecast to 2030”, published by QYResearch, the global Lipid Nanoparticle (LNP) Production Equipment market size is projected to reach USD 0.3 billion by 2030, at a CAGR of 29.9% during the forecast period.

• Global Lipid Nanoparticle (LNP) Production Equipment Market Size (US$ Million), 2019-2030

Source: QYResearch, "Global Lipid Nanoparticle (LNP) Production Equipment Market Insights, Forecast to 2030”

• Global Lipid Nanoparticle (LNP) Production Equipment Top 9 Players RankingandMarket Share (Ranking is based on the revenue of 2023, continually updated)

Source: QYResearch, "Global Lipid Nanoparticle (LNP) Production Equipment Market Insights, Forecast to 2030”

According to QYResearch Top Players Research Center, the global key manufacturers of Lipid Nanoparticle (LNP) Production Equipment include Cytiva, Knauer, Micro&Nano Biologics, RainSure Scientific, Nanowetech (guangzhou) Instrument, etc. In 2023, the global top five players had a share approximately 98.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp